145 related articles for article (PubMed ID: 31132933)
1. Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.
Ivens IA; Banczyk D; Gutberlet K; Jackman S; Vauléon S; Frisk AL
Toxicol Pathol; 2019 Jul; 47(5):585-597. PubMed ID: 31132933
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction.
Baumann A; Piel I; Hucke F; Sandmann S; Hetzel T; Schwarz T
Eur J Pharm Sci; 2019 Mar; 130():11-20. PubMed ID: 30654111
[TBL] [Abstract][Full Text] [Related]
3. Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates.
Stidl R; Fuchs S; Bossard M; Siekmann J; Turecek PL; Putz M
Haemophilia; 2016 Jan; 22(1):54-64. PubMed ID: 26219204
[TBL] [Abstract][Full Text] [Related]
4. Adverse vacuolation in multiple tissues in cynomolgus monkeys following repeat-dose administration of a PEGylated protein.
Fletcher AM; Tellier P; Douville J; Mansell P; Graziano MJ; Mangipudy RS; Brodie TA; Achanzar WE
Toxicol Lett; 2019 Dec; 317():120-129. PubMed ID: 31580884
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development.
Ivens IA; Achanzar W; Baumann A; Brändli-Baiocco A; Cavagnaro J; Dempster M; Depelchin BO; Rovira AR; Dill-Morton L; Lane JH; Reipert BM; Salcedo T; Schweighardt B; Tsuruda LS; Turecek PL; Sims J
Toxicol Pathol; 2015 Oct; 43(7):959-83. PubMed ID: 26239651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T
Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985
[TBL] [Abstract][Full Text] [Related]
7. Chronic Toxicology Studies of Basal Insulin Peglispro in Rats and Dogs: A Novel, PEGylated Insulin Lispro Analog with a Prolonged Duration of Action.
Byrd RA; Blackbourne JL; Knadler MP; Schultze AE; Vahle JL
Toxicol Pathol; 2017 Apr; 45(3):402-415. PubMed ID: 28421968
[TBL] [Abstract][Full Text] [Related]
8. Scientific and Regulatory Policy Committee Points to Consider: Histopathologic Evaluation in Safety Assessment Studies for PEGylated Pharmaceutical Products.
Irizarry Rovira AR; Bennet BM; Bolon B; Braendli-Baiocco A; Chandra S; Fleurance R; Garman R; Hutto D; Lane J; Romeike A; Sargeant A; Zimmerman B
Toxicol Pathol; 2018 Aug; 46(6):616-635. PubMed ID: 30092727
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.
Fang JL; Vanlandingham MM; Beland FA; Felton RP; Maisha MP; Olson GR; Patton RE; Rosenberg AS; Gamboa da Costa G
Toxicol Lett; 2022 Apr; 359():22-30. PubMed ID: 35092809
[TBL] [Abstract][Full Text] [Related]
10. PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.
Turecek PL; Bossard MJ; Schoetens F; Ivens IA
J Pharm Sci; 2016 Feb; 105(2):460-475. PubMed ID: 26869412
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Nonacog Beta Pegol Long-term Safety in the Immune-deficient Rowett Nude Rat (Crl:NIH-Foxn1rnu).
Rasmussen CE; Nowak J; Larsen JM; Bottomley A; Rowles A; Offenberg H
Toxicol Pathol; 2016 Jul; 44(5):726-37. PubMed ID: 26940713
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo.
Tang L; Leong L; Sim D; Ho E; Gu JM; Schneider D; Feldman RI; Monteclaro F; Jiang H; Murphy JE
Haemophilia; 2013 Jul; 19(4):539-45. PubMed ID: 23534820
[TBL] [Abstract][Full Text] [Related]
13. Final report on the safety assessment of Triethylene Glycol and PEG-4.
Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia.
Talpaz M; Rakhit A; Rittweger K; O'Brien S; Cortes J; Fettner S; Hooftman L; Kantarjian H
Clin Cancer Res; 2005 Sep; 11(17):6247-55. PubMed ID: 16144928
[TBL] [Abstract][Full Text] [Related]
15. BAY 94-9027, a PEGylated recombinant factor VIII, exhibits a prolonged half-life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies.
Shah A; Coyle T; Lalezari S; Fischer K; Kohlstaedde B; Delesen H; Radke S; Michaels LA
Haemophilia; 2018 Sep; 24(5):733-740. PubMed ID: 29963724
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
Yu KM; Lau JY; Fok M; Yeung YK; Fok SP; Zhang S; Ye P; Zhang K; Li X; Li J; Xu Q; Wong WT; Choo QL
Toxicol Appl Pharmacol; 2018 Mar; 342():39-49. PubMed ID: 29407773
[TBL] [Abstract][Full Text] [Related]
17. Damoctocog Alfa Pegol: A Review in Haemophilia A.
Paik J; Deeks ED
Drugs; 2019 Jul; 79(10):1147-1156. PubMed ID: 31218660
[TBL] [Abstract][Full Text] [Related]
18. BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.
Turecek PL; Bossard MJ; Graninger M; Gritsch H; Höllriegl W; Kaliwoda M; Matthiessen P; Mitterer A; Muchitsch EM; Purtscher M; Rottensteiner H; Schiviz A; Schrenk G; Siekmann J; Varadi K; Riley T; Ehrlich HJ; Schwarz HP; Scheiflinger F
Hamostaseologie; 2012; 32 Suppl 1():S29-38. PubMed ID: 22961422
[TBL] [Abstract][Full Text] [Related]
19. PEGylated Recombinant Human Growth Hormone Jintrolong
Wu W; Zhou J; Wu C; Zhou Q; Li X; Zhang Y; Zuo C; Yin J; Hou L; Wang S; Gao H; Luo T; Jin L; Zhong E; Wang Y; Luo X
Front Endocrinol (Lausanne); 2022; 13():821588. PubMed ID: 35909512
[TBL] [Abstract][Full Text] [Related]
20. Normal Neurodevelopment and Fertility in Juvenile Male Rats Exposed to Polyethylene Glycol Following Dosing With PEGylated rFIX (Nonacog Beta Pegol, N9-GP): Evidence from a 10-Week Repeat-Dose Toxicity Study.
Jensen VFH; Schefe LH; Jacobsen H; Mølck AM; Almholt K; Sjögren I; Dalsgaard CM; Kirk RK; Benie AJ; Petersen BO; Kyhn MS; Overgaard AJ; Bjørnsdottir I; Stannard DR; Offenberg HK; Egecioglu E
Int J Toxicol; 2022 Dec; 41(6):455-475. PubMed ID: 36036386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
